Skip to main content
AAN.com
Clinical/Scientific Notes
January 17, 2011
video

Progressive encephalomyelitis with rigidity and myoclonus: Resolution after thymectomy

January 18, 2011 issue
76 (3) 303-304
Letters to the Editor
Track CitationsAdd to favorites
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (video_1.mpg)
File (video_2.mpg)
File (video_legend.doc)

References

1.
Meinck H-M, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 2002; 17: 853–866.
2.
Brown P, Marsden CD. The stiff man and stiff man plus syndromes. J Neurol 1999; 246: 648–652.
3.
Molina JA, Porta J, Garcia-Morales I, Bermejo PF, Jiménez-Jiménez FJ. Treatment with intravenous prednisone and immunoglobulin in a case of progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 2000; 68: 395–396.
4.
Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008; 71: 1291–1292.
5.
Brown P, Rothwell JC, Thompson PD, Britton TC, Day BL, Marsden CD. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991; 114: 1903–1928.
6.
Ishii A, Hayashi A, Ohkoshi N, Matsuno S, Shoji S. Progressive encephalomyelitis with rigidity associated with anti-amphiphysin antibodies. J Neurol Neurosurg Psychiatry 2004; 75: 661–662.
7.
Vincent A, Leite MI, Waters P, Jacobi C, Becker CM, Meinck HM. Glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus, hyperekplexia and stiff person syndrome. Ann Neurol 2009; 66 (suppl 13): S50 Abstract.

Information & Authors

Information

Published In

Neurology®
Volume 76Number 3January 18, 2011
Pages: 303-304
PubMed: 21242500

Publication History

Received: March 9, 2010
Accepted: July 28, 2010
Published online: January 17, 2011
Published in print: January 18, 2011

Permissions

Request permissions for this article.

Funding Information

Disclosure: Dr. Clerinx, Dr. Breban, and Dr. Schrooten report no disclosures. Dr. Leite receives research support from the Oxford Biomedical Research Centre, the National Commissioning Group, and the Sir Halley Stewart Trust, UK. Dr. Vincent has served on scientific advisory boards for the Patrick Berthoud Trust and the Myasthenia Gravis Foundation of America; has received funding for travel and a speaker honorarium from Baxter International Inc.; serves as an Associate Editor for Brain; receives royalties from the publication of Clinical Neuroimmunology (Blackwell Publishing, 2005); receives research support from the European Union, NIHR Biomedical Research Centre Oxford, and Sir Halley Stewart Trust; and has received Musk antibody royalties and consulting fees from Athena Diagnostics, Inc., and Musk antibody royalties from RSR Ltd., Cardiff, UK. The University of Oxford, where A.V. is based, receives royalties and payments for antibody assays in neurologic diseases. Dr. Verschakelen, Dr. Tousseyn, and Dr. Vandenberghe report no disclosures.

Authors

Affiliations & Disclosures

K. Clerinx, MD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
T. Breban, MD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
M. Schrooten, MD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
M.I. Leite, MD, DPhil
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
A. Vincent, FRCPath
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
J. Verschakelen, MD, PhD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
T. Tousseyn, MD, PhD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.
W. Vandenberghe, MD, PhD
From the Departments of Neurology (K.C., T.B., M.S., W.V.), Radiology (J.V.), and Pathology (T.T.), University Hospitals Leuven, Leuven, Belgium; and Department of Clinical Neurology (M.I.L., A.V.), University of Oxford, Oxford, UK.

Notes

Address correspondence and reprint requests to Dr. Wim Vandenberghe, Department of Neurology, University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium; [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Stiff person syndrome, Neurologic Channelopathies, (211-233), (2024).https://doi.org/10.1016/B978-0-323-90820-7.00003-3
    Crossref
  2. Paraneoplastic autoimmune neurologic disorders associated with thymoma, Paraneoplastic Neurologic Disorders, (385-396), (2024).https://doi.org/10.1016/B978-0-12-823912-4.00008-6
    Crossref
  3. Stiff-Person Syndrome Spectrum Disorders, Neuroimmune Diseases, (863-896), (2024).https://doi.org/10.1007/978-3-031-60006-7_20
    Crossref
  4. Stiff-Person Syndrome Spectrum Disorders, Neuroimmune Diseases, (1-34), (2024).https://doi.org/10.1007/978-3-031-24297-7_20-1
    Crossref
  5. Abnormal Movements in Neurological Autoimmune Disorders, Autoimmune Encephalitis and Related Disorders of the Nervous System, (545-562), (2022).https://doi.org/10.1017/9781108696722.022
    Crossref
  6. Progressive encephalomyelitis with rigidity: A Taiwanese case and review of literature, Clinical Neurology and Neurosurgery, 208, (106807), (2021).https://doi.org/10.1016/j.clineuro.2021.106807
    Crossref
  7. Progressive Encephalomyelitis With Rigidity and Myoclonus With Thymoma: A Case Report and Literature Review, Frontiers in Neurology, 11, (2020).https://doi.org/10.3389/fneur.2020.01017
    Crossref
  8. Paraneoplastic Neurologic Syndromes, Abeloff's Clinical Oncology, (676-687.e5), (2020).https://doi.org/10.1016/B978-0-323-47674-4.00044-X
    Crossref
  9. Stiff-Person Syndrome Spectrum Disorders, Neuroimmune Diseases, (621-649), (2019).https://doi.org/10.1007/978-3-030-19515-1_20
    Crossref
  10. Paraneoplastic Neurological Syndromes, Neuroimmune Diseases, (439-485), (2019).https://doi.org/10.1007/978-3-030-19515-1_14
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share